Literature DB >> 7683861

Fibrinogen binds to heparin: the relationship of the binding of other adhesive proteins to heparin.

H Mohri1, T Ohkubo.   

Abstract

The binding of heparin to fibrinogen was characterized. We have used an assay employing heparin coupled to Sepharose CL-6B to show that 125I-fibrinogen binds to heparin in a time-dependent, divalent ion-independent, saturable, and reversible manner. A total of 1.75 mg of fibrinogen could bind to 1 ml of heparin-Sepharose CL-6B with a Kd of 4.03 x 10(-7) M. Binding was completely inhibited by other adhesive proteins including fibronectin, von Willebrand factor (vWF), and vitronectin with IC50s of 7.2-8.8 microM. The binding of 125I-fibrinogen to heparin-Sepharose CL-6B was blocked by a monoclonal antibody (52k-2) and a polyclonal antibody (FK-2). 52k-2 inhibits the binding of vWF, and FK-2 blocks the binding of fibronectin to heparin-Sepharose CL-6B. It is therefore likely that fibrinogen has a heparin-binding site(s) which may have some overlap with those of other adhesive proteins, although the physiological role of the fibrinogen heparin-binding domain is uncertain at present.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683861     DOI: 10.1006/abbi.1993.1251

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  3 in total

1.  Interaction of heparin with synthetic peptides corresponding to the C-terminal domain of intestinal mucins.

Authors:  G Xu; G G Forstner; J F Forstner
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

2.  Fibrinogen, riboflavin, and UVA to immobilize a corneal flap--molecular mechanisms.

Authors:  Stacy L Littlechild; Yuntao Zhang; John M Tomich; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-06       Impact factor: 4.799

3.  Heparin Binding Sites Are Located in a 40-kD gamma-Chain and a 36-kD beta-Chain Fragment Isolated from Human Fibrinogen.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1994       Impact factor: 2.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.